Petros Pharmaceuticals, Inc.
PTPI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4 | $13 | $9 | $24 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $2 | $2 | $3 |
| Inventory | $3 | $2 | $2 | $1 |
| Other Curr. Assets | $0 | $3 | $1 | $3 |
| Total Curr. Assets | $7 | $20 | $15 | $31 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $3 | $9 | $12 | $25 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $4 | $5 | $11 |
| Total NC Assets | $3 | $13 | $18 | $37 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $11 | $34 | $32 | $67 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $2 | $5 |
| Short-Term Debt | $7 | $1 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $2 | $0 | -$0 |
| Other Curr. Liab. | $8 | $6 | $4 | $26 |
| Total Curr. Liab. | $18 | $11 | $7 | $31 |
| LT Debt | $0 | $7 | $9 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $4 | $0 | $0 |
| Total NC Liab. | $0 | $11 | $9 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $18 | $21 | $16 | $32 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$113 | -$99 | -$91 | -$71 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $106 | $111 | $107 | $106 |
| Total Equity | -$7 | $12 | $17 | $36 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $11 | $34 | $32 | $67 |
| Net Debt | $4 | -$5 | $0 | -$23 |